The Valley hospital

Ridgewood, New Jersey 07451

7 studies enrolling now · 96 studies all time

What they study most

Acute Coronary Syndrome, Acute Myocardial Infarction, Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Angina Pectoris, Aortic Insufficiency, Aortic Stenosis, Aortic Stenosis, Calcific, Aortic Stenosis, Severe, Aortic Valve Insufficiency, Aortic Valve Stenosis, Apnea, Arrhythmia

Studies at this site

• An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) — Recruiting now
• ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves — Recruiting now
• Phase IIIb Study of Ribociclib + ET in Early Breast Cancer — Recruiting now
• BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT — Recruiting now
• ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve — Recruiting now
• Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women — Recruiting now
• PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR — Recruiting now
• Comparing Hypothermic Temperatures During Hemiarch Surgery — Recruiting now
• iCLAS™ for Persistent Atrial Fibrillation — Completed
• PROACTIVE-HF IDE Trial Heart Failure NYHA Class III — Running, not enrolling
• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION) — Running, not enrolling
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• Impact of Swaddle Blanket on Gastroesophageal Reflux — Completed
• Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD — Running, not enrolling
• Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD — Running, not enrolling
• Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation — Completed
• Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment — Running, not enrolling
• Impella ECP Study (ECP Study) and Impella ECP Continued Access Protocol — Enrolling by invitation
• Micra AV Transcatheter Pacing System Post-Approval Registry — Completed
• Optimize PRO Study — Completed
• Safety and Effectiveness Evaluation of the Multi-Electrode Radiofrequency Balloon Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation — Completed
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• DEFINE AFib (Atrial Fibrillation) — Stopped early
• A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer — Stopped early
• Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction — Completed
• Comparison of Surgeons' Object Discernment Via Their Hands Versus Using a Robotic Surgical System That Does Not Incorporate Haptics — Completed
• Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF — Completed
• STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation — Completed
• Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation — Completed
• Welch Emotional Connection Screen (WECS) in the NICU — Completed
• Viz HCM (ECG Assist) Utilization Workflow Pilot — Completed
• Physiologic Pacing Registry — Completed
• Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study — Completed
• Clinical Investigation of the da Vinci Surgical System — Running, not enrolling
• Feasibility of Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic, Severe Aortic Stenosis — Completed
• aMAZE Trial Continued Access Protocol — Completed
• Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19 — Completed
• Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation — Completed
• XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort — Completed
• ABSORB III Randomized Controlled Trial (RCT) — Completed
• Electrocardiographic Diagnostic Performance of the Apple Watch Augmented With an Artificial Intelligence Algorithm — Completed
• TYRX™ Pocket Health Study — Completed
• A PRospective, rAndomizEd Comparison of subcuTaneOous and tRansvenous ImplANtable Cardioverter Defibrillator Therapy — Status unconfirmed
• PerQseal®+ Early Feasibility Study — Completed
• PerQseal® Impella Early Feasibility Study — Completed
• AMBULATE: Cardiva Mid-Bore VVCS vs. Manual Compression for Multiple Femoral Venous Access Sites, 6 - 12F ID — Completed
• Tipifarnib and Osimertinib in EGFR-mutated Non-Small Cell Lung Cancer — Withdrawn before enrolling
• Family Nurture Intervention in the NICU at The Valley Hospital — Completed
• A Study of Tilsotolimod in Combo With Ipilimumab vs Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma — Stopped early